• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正电子发射断层扫描评估阿尔茨海默病中内侧颞叶tau 病的皮质起源和初始扩散。

The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography.

机构信息

Massachusetts General Hospital, Boston, MA 02114, USA.

Harvard Medical School, Boston, MA 02115, USA.

出版信息

Sci Transl Med. 2021 Jan 20;13(577). doi: 10.1126/scitranslmed.abc0655.

DOI:10.1126/scitranslmed.abc0655
PMID:33472953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7978042/
Abstract

Advances in molecular positron emission tomography (PET) have enabled anatomic tracking of brain pathology in longitudinal studies of normal aging and dementia, including assessment of the central model of Alzheimer's disease (AD) pathogenesis, according to which TAU pathology begins focally but expands catastrophically under the influence of amyloid-β (Aβ) pathology to mediate neurodegeneration and cognitive decline. Initial TAU deposition occurs many years before Aβ in a specific area of the medial temporal lobe. Building on recent work that enabled focus of molecular PET measurements on specific TAU-vulnerable convolutional temporal lobe anatomy, we applied an automated anatomic sampling method to quantify TAU PET signal in 443 adult participants from several observational studies of aging and AD, spanning a wide range of ages, Aβ burdens, and degrees of clinical impairment. We detected initial cortical emergence of tauopathy near the rhinal sulcus in clinically normal people and, in a subset with longitudinal 2-year follow-up data ( = 104), tracked Aβ-associated spread of TAU from this site first to nearby neocortex of the temporal lobe and then to extratemporal regions. Greater rate of TAU spread was associated with baseline measures of both global Aβ burden and medial temporal lobe TAU. These findings are consistent with clinicopathological correlation studies of Alzheimer's tauopathy and enable precise tracking of AD-related TAU progression for natural history studies and prevention therapeutic trials.

摘要

分子正电子发射断层扫描 (PET) 的进展使得能够在正常衰老和痴呆症的纵向研究中对脑病理学进行解剖追踪,包括评估阿尔茨海默病 (AD) 发病机制的中心模型,根据该模型,tau 病理学首先在局部开始,但在淀粉样蛋白-β (Aβ) 病理学的影响下灾难性地扩展,介导神经退行性变和认知能力下降。tau 沉积物最初出现在内侧颞叶的特定区域,比 Aβ 早多年。基于最近的一项工作,该工作使得能够将分子 PET 测量重点集中在特定的 tau 易损性卷积颞叶解剖结构上,我们应用了一种自动解剖采样方法来量化来自几个衰老和 AD 观察性研究的 443 名成年参与者的 tau PET 信号,这些研究涵盖了广泛的年龄、Aβ 负担和临床损伤程度。我们在临床正常人群中检测到了靠近嗅沟的 tau 病的初始皮质出现,并且在具有 2 年纵向随访数据的亚组中(= 104),从该部位首先追踪到了与 Aβ 相关的 tau 从颞叶附近的新皮质扩散,然后扩散到颞叶以外的区域。tau 扩散的速度越快,与全局 Aβ 负担和内侧颞叶 tau 的基线测量值越高。这些发现与阿尔茨海默氏 tau 病的临床病理相关性研究一致,并为自然史研究和预防治疗试验实现了 AD 相关 tau 进展的精确追踪。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c366/7978042/087b5fcd01c6/nihms-1677705-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c366/7978042/ce0f7e8cc7e6/nihms-1677705-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c366/7978042/c9528d63dfcc/nihms-1677705-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c366/7978042/b061dc25b621/nihms-1677705-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c366/7978042/d64f34334886/nihms-1677705-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c366/7978042/90334ea04f49/nihms-1677705-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c366/7978042/087b5fcd01c6/nihms-1677705-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c366/7978042/ce0f7e8cc7e6/nihms-1677705-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c366/7978042/c9528d63dfcc/nihms-1677705-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c366/7978042/b061dc25b621/nihms-1677705-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c366/7978042/d64f34334886/nihms-1677705-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c366/7978042/90334ea04f49/nihms-1677705-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c366/7978042/087b5fcd01c6/nihms-1677705-f0006.jpg

相似文献

1
The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography.正电子发射断层扫描评估阿尔茨海默病中内侧颞叶tau 病的皮质起源和初始扩散。
Sci Transl Med. 2021 Jan 20;13(577). doi: 10.1126/scitranslmed.abc0655.
2
Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.主观认知衰退与tau蛋白病的区域特异性关联,独立于整体β-淀粉样蛋白负荷。
JAMA Neurol. 2017 Dec 1;74(12):1455-1463. doi: 10.1001/jamaneurol.2017.2216.
3
Age-related and amyloid-beta-independent tau deposition and its downstream effects.与年龄相关且与淀粉样β蛋白无关的tau 沉积及其下游效应。
Brain. 2023 Aug 1;146(8):3192-3205. doi: 10.1093/brain/awad135.
4
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.比较多种 tau-PET 指标作为衰老和阿尔茨海默病的生物标志物。
Neuroimage. 2017 Aug 15;157:448-463. doi: 10.1016/j.neuroimage.2017.05.058. Epub 2017 Jun 3.
5
Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity.内侧颞叶tau 正电子发射断层扫描摄取增加而淀粉样β 呈阴性。
JAMA Neurol. 2023 Oct 1;80(10):1051-1061. doi: 10.1001/jamaneurol.2023.2560.
6
Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.tau PET 于常染色体显性阿尔茨海默病:与认知、痴呆和其他生物标志物的关系。
Brain. 2019 Apr 1;142(4):1063-1076. doi: 10.1093/brain/awz019.
7
Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies.淀粉样蛋白和 Tau 预测认知和功能下降在认知正常的老年人:来自 A4 和 LEARN 研究的纵向数据。
J Prev Alzheimers Dis. 2024;11(4):802-813. doi: 10.14283/jpad.2024.122.
8
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.氟替卡匹尔PET tau蛋白结合与淀粉样蛋白负荷、临床诊断、年龄和认知之间的关系。
Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334.
9
Reduced Repetition Suppression in Aging is Driven by Tau-Related Hyperactivity in Medial Temporal Lobe.衰老导致重复抑制减少是由内侧颞叶tau 相关过度活跃引起的。
J Neurosci. 2021 Apr 28;41(17):3917-3931. doi: 10.1523/JNEUROSCI.2504-20.2021. Epub 2021 Mar 17.
10
A data-driven study of Alzheimer's disease related amyloid and tau pathology progression.基于数据的阿尔茨海默病相关淀粉样蛋白和tau 病理进展研究。
Brain. 2023 Dec 1;146(12):4935-4948. doi: 10.1093/brain/awad232.

引用本文的文献

1
Concurrent Changes in Plasma Phosphorylated Tau 217, Tau PET, and Cognition in Preclinical Alzheimer Disease.临床前阿尔茨海默病患者血浆磷酸化tau 217、tau PET与认知的同步变化
JAMA Neurol. 2025 Aug 25. doi: 10.1001/jamaneurol.2025.2974.
2
AI-driven fusion of multimodal data for Alzheimer's disease biomarker assessment.用于阿尔茨海默病生物标志物评估的多模态数据的人工智能驱动融合。
Nat Commun. 2025 Aug 11;16(1):7407. doi: 10.1038/s41467-025-62590-4.
3
Developing an Anatomically Valid Segmentation Protocol for Anterior Regions of the Medial Temporal Lobe for Neurodegenerative Diseases.

本文引用的文献

1
Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age.淀粉样蛋白和 tau 成像生物标志物解释从中年后期开始的认知能力下降。
Brain. 2020 Jan 1;143(1):320-335. doi: 10.1093/brain/awz378.
2
Cortical tau deposition follows patterns of entorhinal functional connectivity in aging.皮质tau 沉积遵循衰老过程中内嗅皮层功能连接的模式。
Elife. 2019 Sep 2;8:e49132. doi: 10.7554/eLife.49132.
3
Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study.临床前阿尔茨海默病中淀粉样蛋白和tau蛋白与认知的关联:一项纵向研究。
为神经退行性疾病开发一种用于内侧颞叶前部区域的解剖学上有效的分割方案。
Hippocampus. 2025 Sep;35(5):e70027. doi: 10.1002/hipo.70027.
4
Decreased quantitative transport mapping velocity in the middle cerebral artery-supplied temporal lobe in Alzheimer's disease.阿尔茨海默病患者大脑中动脉供血的颞叶定量转运图谱速度降低。
Alzheimers Dement. 2025 Aug;21(8):e70540. doi: 10.1002/alz.70540.
5
Cognitive decline in community-dwelling older persons with primary age-related tauopathy: role of anatomical location of tangles and other co-existing brain pathologies.社区居住的患有原发性年龄相关性tau蛋白病的老年人的认知衰退:缠结的解剖位置及其他并存脑病理学的作用
Acta Neuropathol. 2025 Jul 24;150(1):8. doi: 10.1007/s00401-025-02916-0.
6
Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease.高等教育程度与阿尔茨海默病中tau蛋白的加速积累
JAMA Neurol. 2025 Jul 7. doi: 10.1001/jamaneurol.2025.1801.
7
Midlife Steroid-Binding Globulin Levels and In Vivo Neuroimaging Measures of Tau in Older Men and Women.中年男性和女性体内类固醇结合球蛋白水平与tau蛋白的活体神经影像学测量
Ann Neurol. 2025 Sep;98(3):524-532. doi: 10.1002/ana.27266. Epub 2025 Jun 14.
8
Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease.了解β-淀粉样蛋白靶向疗法对阿尔茨海默病生物标志物和临床终点的影响。
Alzheimers Dement (N Y). 2025 May 24;11(2):e70069. doi: 10.1002/trc2.70069. eCollection 2025 Apr-Jun.
9
Multimodal spatial gradients to explain regional susceptibility to fibrillar tau in Alzheimer's disease.多模态空间梯度解释阿尔茨海默病中区域对纤维状tau蛋白的易感性。
Alzheimers Dement. 2025 May;21(5):e70170. doi: 10.1002/alz.70170.
10
Spatial-temporal interactions between white matter hyperintensities and multiple pathologies across the Alzheimer's disease continuum.阿尔茨海默病连续体中白质高信号与多种病理之间的时空相互作用。
Alzheimers Dement. 2025 Apr;21(4):e70098. doi: 10.1002/alz.70098.
JAMA Neurol. 2019 Aug 1;76(8):915-924. doi: 10.1001/jamaneurol.2019.1424.
4
Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults.tau-PET 信号与认知功能正常成年人认知功能的横断面相关性。
Neurology. 2019 Jul 2;93(1):e29-e39. doi: 10.1212/WNL.0000000000007728. Epub 2019 May 30.
5
Automated segmentation of medial temporal lobe subregions on in vivo T1-weighted MRI in early stages of Alzheimer's disease.阿尔茨海默病早期活体 T1 加权 MRI 上内侧颞叶亚区的自动分割。
Hum Brain Mapp. 2019 Aug 15;40(12):3431-3451. doi: 10.1002/hbm.24607. Epub 2019 Apr 29.
6
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.多中心纵向研究氟替卡滨(18F)在正常衰老、轻度认知障碍和阿尔茨海默病痴呆中的作用。
Brain. 2019 Jun 1;142(6):1723-1735. doi: 10.1093/brain/awz090.
7
Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease.非典型阿尔茨海默病中 tau-PET 摄取和萎缩的纵向研究。
Neuroimage Clin. 2019;23:101823. doi: 10.1016/j.nicl.2019.101823. Epub 2019 Apr 10.
8
Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study.阿尔茨海默病中 Tau 蛋白的进行性积累:2 年随访研究。
J Nucl Med. 2019 Nov;60(11):1611-1621. doi: 10.2967/jnumed.118.221697. Epub 2019 Mar 29.
9
Longitudinal tau accumulation and atrophy in aging and alzheimer disease.tau 蛋白在衰老和阿尔茨海默病中的纵向积累和萎缩。
Ann Neurol. 2019 Feb;85(2):229-240. doi: 10.1002/ana.25406. Epub 2019 Jan 17.
10
Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology.体内 [18F]Flortaucipir 与死后阿尔茨海默病 Tau 病理学的相关性。
JAMA Neurol. 2019 Mar 1;76(3):310-317. doi: 10.1001/jamaneurol.2018.3692.